Report Detail

Request for Sample of this report

Other Global Oncology Based Preclinical CRO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4528541
    • |
  • 13 April, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
According to our (Global Info Research) latest study, the global Oncology Based Preclinical CRO market size was valued at USD 391.3 million in 2022 and is forecast to a readjusted size of USD 857.9 million by 2029 with a CAGR of 11.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
This report is a detailed and comprehensive analysis for global Oncology Based Preclinical CRO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Based Preclinical CRO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oncology Based Preclinical CRO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oncology Based Preclinical CRO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oncology Based Preclinical CRO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Based Preclinical CRO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Based Preclinical CRO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Crown Bioscience, Charles River, ICON, Eurofins Scientific and Taconic Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oncology Based Preclinical CRO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Blood Cancer
Solid Tumors
Others
Market segment by Application
In Vitro
In Vivo
Market segment by players, this report covers
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Based Preclinical CRO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Based Preclinical CRO, with revenue, gross margin and global market share of Oncology Based Preclinical CRO from 2018 to 2023.
Chapter 3, the Oncology Based Preclinical CRO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncology Based Preclinical CRO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Based Preclinical CRO.
Chapter 13, to describe Oncology Based Preclinical CRO research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Oncology Based Preclinical CRO
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oncology Based Preclinical CRO by Type
    • 1.3.1 Overview: Global Oncology Based Preclinical CRO Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Oncology Based Preclinical CRO Consumption Value Market Share by Type in 2022
    • 1.3.3 Blood Cancer
    • 1.3.4 Solid Tumors
    • 1.3.5 Others
  • 1.4 Global Oncology Based Preclinical CRO Market by Application
    • 1.4.1 Overview: Global Oncology Based Preclinical CRO Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 In Vitro
    • 1.4.3 In Vivo
  • 1.5 Global Oncology Based Preclinical CRO Market Size & Forecast
  • 1.6 Global Oncology Based Preclinical CRO Market Size and Forecast by Region
    • 1.6.1 Global Oncology Based Preclinical CRO Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Oncology Based Preclinical CRO Market Size by Region, (2018-2029)
    • 1.6.3 North America Oncology Based Preclinical CRO Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Oncology Based Preclinical CRO Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Oncology Based Preclinical CRO Market Size and Prospect (2018-2029)
    • 1.6.6 South America Oncology Based Preclinical CRO Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Oncology Based Preclinical CRO Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Crown Bioscience
    • 2.1.1 Crown Bioscience Details
    • 2.1.2 Crown Bioscience Major Business
    • 2.1.3 Crown Bioscience Oncology Based Preclinical CRO Product and Solutions
    • 2.1.4 Crown Bioscience Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Crown Bioscience Recent Developments and Future Plans
  • 2.2 Charles River
    • 2.2.1 Charles River Details
    • 2.2.2 Charles River Major Business
    • 2.2.3 Charles River Oncology Based Preclinical CRO Product and Solutions
    • 2.2.4 Charles River Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Charles River Recent Developments and Future Plans
  • 2.3 ICON
    • 2.3.1 ICON Details
    • 2.3.2 ICON Major Business
    • 2.3.3 ICON Oncology Based Preclinical CRO Product and Solutions
    • 2.3.4 ICON Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 ICON Recent Developments and Future Plans
  • 2.4 Eurofins Scientific
    • 2.4.1 Eurofins Scientific Details
    • 2.4.2 Eurofins Scientific Major Business
    • 2.4.3 Eurofins Scientific Oncology Based Preclinical CRO Product and Solutions
    • 2.4.4 Eurofins Scientific Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.5 Taconic Biosciences
    • 2.5.1 Taconic Biosciences Details
    • 2.5.2 Taconic Biosciences Major Business
    • 2.5.3 Taconic Biosciences Oncology Based Preclinical CRO Product and Solutions
    • 2.5.4 Taconic Biosciences Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Taconic Biosciences Recent Developments and Future Plans
  • 2.6 Covance
    • 2.6.1 Covance Details
    • 2.6.2 Covance Major Business
    • 2.6.3 Covance Oncology Based Preclinical CRO Product and Solutions
    • 2.6.4 Covance Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Covance Recent Developments and Future Plans
  • 2.7 EVOTEC
    • 2.7.1 EVOTEC Details
    • 2.7.2 EVOTEC Major Business
    • 2.7.3 EVOTEC Oncology Based Preclinical CRO Product and Solutions
    • 2.7.4 EVOTEC Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 EVOTEC Recent Developments and Future Plans
  • 2.8 The Jackson Laboratory
    • 2.8.1 The Jackson Laboratory Details
    • 2.8.2 The Jackson Laboratory Major Business
    • 2.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Product and Solutions
    • 2.8.4 The Jackson Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 The Jackson Laboratory Recent Developments and Future Plans
  • 2.9 MI Bioresearch
    • 2.9.1 MI Bioresearch Details
    • 2.9.2 MI Bioresearch Major Business
    • 2.9.3 MI Bioresearch Oncology Based Preclinical CRO Product and Solutions
    • 2.9.4 MI Bioresearch Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 MI Bioresearch Recent Developments and Future Plans
  • 2.10 Champion Oncology
    • 2.10.1 Champion Oncology Details
    • 2.10.2 Champion Oncology Major Business
    • 2.10.3 Champion Oncology Oncology Based Preclinical CRO Product and Solutions
    • 2.10.4 Champion Oncology Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Champion Oncology Recent Developments and Future Plans
  • 2.11 Wuxi AppTec.
    • 2.11.1 Wuxi AppTec. Details
    • 2.11.2 Wuxi AppTec. Major Business
    • 2.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Product and Solutions
    • 2.11.4 Wuxi AppTec. Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Wuxi AppTec. Recent Developments and Future Plans
  • 2.12 Xentech
    • 2.12.1 Xentech Details
    • 2.12.2 Xentech Major Business
    • 2.12.3 Xentech Oncology Based Preclinical CRO Product and Solutions
    • 2.12.4 Xentech Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Xentech Recent Developments and Future Plans
  • 2.13 Living Tumor Laboratory
    • 2.13.1 Living Tumor Laboratory Details
    • 2.13.2 Living Tumor Laboratory Major Business
    • 2.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Product and Solutions
    • 2.13.4 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Living Tumor Laboratory Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oncology Based Preclinical CRO Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Oncology Based Preclinical CRO by Company Revenue
    • 3.2.2 Top 3 Oncology Based Preclinical CRO Players Market Share in 2022
    • 3.2.3 Top 6 Oncology Based Preclinical CRO Players Market Share in 2022
  • 3.3 Oncology Based Preclinical CRO Market: Overall Company Footprint Analysis
    • 3.3.1 Oncology Based Preclinical CRO Market: Region Footprint
    • 3.3.2 Oncology Based Preclinical CRO Market: Company Product Type Footprint
    • 3.3.3 Oncology Based Preclinical CRO Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oncology Based Preclinical CRO Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Oncology Based Preclinical CRO Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Oncology Based Preclinical CRO Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Oncology Based Preclinical CRO Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Oncology Based Preclinical CRO Consumption Value by Type (2018-2029)
  • 6.2 North America Oncology Based Preclinical CRO Consumption Value by Application (2018-2029)
  • 6.3 North America Oncology Based Preclinical CRO Market Size by Country
    • 6.3.1 North America Oncology Based Preclinical CRO Consumption Value by Country (2018-2029)
    • 6.3.2 United States Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Oncology Based Preclinical CRO Consumption Value by Type (2018-2029)
  • 7.2 Europe Oncology Based Preclinical CRO Consumption Value by Application (2018-2029)
  • 7.3 Europe Oncology Based Preclinical CRO Market Size by Country
    • 7.3.1 Europe Oncology Based Preclinical CRO Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 7.3.3 France Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oncology Based Preclinical CRO Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Oncology Based Preclinical CRO Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region
    • 8.3.1 Asia-Pacific Oncology Based Preclinical CRO Consumption Value by Region (2018-2029)
    • 8.3.2 China Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 8.3.5 India Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Oncology Based Preclinical CRO Consumption Value by Type (2018-2029)
  • 9.2 South America Oncology Based Preclinical CRO Consumption Value by Application (2018-2029)
  • 9.3 South America Oncology Based Preclinical CRO Market Size by Country
    • 9.3.1 South America Oncology Based Preclinical CRO Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oncology Based Preclinical CRO Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Oncology Based Preclinical CRO Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country
    • 10.3.1 Middle East & Africa Oncology Based Preclinical CRO Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Oncology Based Preclinical CRO Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Oncology Based Preclinical CRO Market Drivers
  • 11.2 Oncology Based Preclinical CRO Market Restraints
  • 11.3 Oncology Based Preclinical CRO Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Oncology Based Preclinical CRO Industry Chain
  • 12.2 Oncology Based Preclinical CRO Upstream Analysis
  • 12.3 Oncology Based Preclinical CRO Midstream Analysis
  • 12.4 Oncology Based Preclinical CRO Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oncology Based Preclinical CRO. Industry analysis & Market Report on Oncology Based Preclinical CRO is a syndicated market report, published as Global Oncology Based Preclinical CRO Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Oncology Based Preclinical CRO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,232.92
    		4,849.38
    		6,465.84
    		532,196.40
    		798,294.60
    		1,064,392.80
    		290,301.60
    		435,452.40
    		580,603.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo